Low Glycemic Index Carbohydrates versus All Types of Carbohydrates for Treating Diabetes in Pregnancy: A Randomized Clinical Trial to Evaluate the Effect of Glycemic Control

Table 3

Group differences in plasma and capillary glucose concentration (mg/dL) throughout the intervention ().


	Group 1 (All types of CHO) ()				Group 2 (Low GI CHO) ()				value^b, c
	T1	T2	T3	value^a	T1	T2	T3	value^a	value^b, c

Plasma fasting (mg/dL)	104.10 ± 31.83	92.07 ± 17.05	90.06 ± 15.64	0.003 *	95.05 ± 13.97	91.82 ± 12.39	88.18 ± 13.83	0.004 *	0.502
Capillary (mg/dL)
Fasting	96.00 ± 13.91	90.32 ± 11.25	85.57 ± 11.78	0.001 *	96.25 ± 12.21	91.78 ± 8.40	88.20 ± 12.06	0.001 *	0.375
2 h-postprandial breakfast	105.45 ± 19.50	108.43 ± 15.31	106.21 ± 17.00	0.817	108.76 ± 19.10	106.65 ± 12.35	103.89 ± 16.69	0.068	0.874
Preprandial lunch	90.88 ± 16.02	87.98 ± 12.17	88.92 ± 13.78	0.481	88.85 ± 11.79	87.95 ± 8.09	89.20 ± 12.20	0.868	0.074
2 h-postprandial lunch	119.16 ± 16.15	118.27 ± 14.96	115.59 ± 14.96	0.179	118.79 ± 21.98	114.35 ± 13.97	115.51 ± 17.82	0.344	0.351
Preprandial dinner	96.92 ± 13.37	98.46 ± 15.88	96.42 ± 16.70	0.849	99.18 ± 18.26	96.14 ± 9.38	96.22 ± 12.74	0.221	0.298
2 h-postprandial dinner	108.97 ± 12.78	111.75 ± 13.21	111.78 ± 15.42	0.346	116.20 ± 21.96	111.82 ± 13.79	110.37 ± 14.92	0.084	0.448

Mean ± SD analyzed by repeated measures ANOVA (factors: study group and type of DM).
^aIntra-group differences, ^binter-group differences.
^cEstimated effect size Eta² in all comparisons.
*Significant decrease throughout time ().
Type of DM was a nonsignificant factor in the analysis ().
T1: first visit value, T2: mean values throughout pregnancy, and T3: last visit value.

International Journal of Endocrinology

Low Glycemic Index Carbohydrates versus All Types of Carbohydrates for Treating Diabetes in Pregnancy: A Randomized Clinical Trial to Evaluate the Effect of Glycemic Control

Table 3